These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 4576147

  • 1. The newer antibiotics.
    Ries K, Kaye D.
    Med Clin North Am; 1973 Jul; 57(4):1065-78. PubMed ID: 4576147
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Adverse effects of antibiotics.
    Johnson AH.
    Semin Drug Treat; 1972 Jul; 2(3):331-49. PubMed ID: 4376622
    [No Abstract] [Full Text] [Related]

  • 5. The susceptibility of Bacteroides fragilis to 24 antibiotics.
    Kislak JW.
    J Infect Dis; 1972 Mar; 125(3):295-9. PubMed ID: 4335792
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Appearance of exanthema during hing-dosage therapy with beta-lacta antibiotics].
    Spitzy KH.
    Acta Med Austriaca; 1974 Mar; 2(1):46-8. PubMed ID: 4282696
    [No Abstract] [Full Text] [Related]

  • 8. Notes on some recent antibiotic literature. II. The new antibiotics.
    Shapiro SL.
    Eye Ear Nose Throat Mon; 1971 Dec; 50(12):492-6. PubMed ID: 4941105
    [No Abstract] [Full Text] [Related]

  • 9. Newer antibiotic agents acting on gram-negative organisms.
    Hill HR, Matsen JM.
    Geriatrics; 1973 Aug; 28(8):72-6. PubMed ID: 4212199
    [No Abstract] [Full Text] [Related]

  • 10. Initial therapy with combination of five antibiotics in febrile patients with leukaemia and neutropenia.
    Tattersall MH, Spiers AS, Darrell JH.
    Lancet; 1972 Jan 22; 1(7743):162-5. PubMed ID: 4109545
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Isolation rate of Pseudomonas aeruginosa from clinical materials and its susceptibility to antibiotics].
    Oguri T, Kosakai N.
    Jpn J Antibiot; 1971 Jun 22; 24(3):121-5. PubMed ID: 4327335
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of anaerobic infections with lincomycin and clindamycin.
    Bartlett JG, Sutter VL, Finegold SM.
    N Engl J Med; 1972 Nov 16; 287(20):1006-10. PubMed ID: 4346707
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment failures secondary to in vivo development of drug resistance by microorganisms.
    Sugarman B, Pesanti E.
    Rev Infect Dis; 1980 Nov 16; 2(2):153-68. PubMed ID: 6771864
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.